Tickers

1. Composite Trajectory Verdict

Given PTC's subscription software model with high recurring revenue and predictable upfront billing, the cash flow statement carries the most weight for assessing financial performance, as it reflects the conversion of ARR and contract billings into liquidity, while the income statement is materially affected by ASC 606 timing differences and the recent divestiture.

Composite Trajectory: Mixed

Cash generation shows consistent improvement across all comparable periods (annual, nine-month, and quarterly), with operating cash flow growing 16% in FY'25, 11% in the first nine months of FY'26, and 7% in Q3'26 year-over-year. The balance sheet reflects a deliberate shift: net debt fell from ~$1.49B at September 2024 to ~$1.02B at September 2025, then rose to ~$1.07B at June 2026 as the company borrowed $225M on its revolver to fund $1.33B of share repurchases in the first nine months of FY'26. The income statement is distorted by the Q2'26 Kepware and ThingWorx divestiture: nine-month GAAP net income surged 127% to $876M but included a $463M divestiture gain, while Q3'26 revenue fell 7% and operating income fell 21% year-over-year due to the loss of $46M of quarterly revenue from the divested businesses. Excluding the divested businesses, ARR grew 7% (9% constant currency) and nine-month recurring revenue grew 14% (10% constant currency).

2. Red Flags

• GAAP net income inflated by large non-recurring gain: Nine-month FY'26 net income of $876.0M includes a $462.6M gain on the Kepware and ThingWorx divestiture recognized in Other income, net (10-Q 2026-06-30, Condensed Statements of Operations).
• Aggressive share repurchases funded by debt: $1.326B of repurchases in nine months FY'26 (vs. $225M in prior year) partially funded by $225M net revolver borrowings, reducing additional paid-in capital from $1.823B to $611M (10-Q 2026-06-30, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, Consolidated Balance Sheets).
• Rising current liabilities: Accrued expenses and other current liabilities jumped from $136.1M at September 2025 to $300.6M at June 2026, and accrued income taxes rose from $28.7M to $85.2M, partly reflecting divestiture-related tax liabilities (10-Q 2026-06-30, Consolidated Balance Sheets).
• Divergence between GAAP and non-GAAP operating margin in Q3'26: GAAP operating margin fell 480 bps to 27.7% while non-GAAP operating margin fell 290 bps to 41.4%, with acquisition/divestiture charges of $2.9M in Q3 and $40M in nine months FY'26 (10-Q 2026-06-30, MD&A Operating Expenses; Non-GAAP reconciliation).
• Large unrecognized tax benefit: $109.2M unrecognized tax benefit related to IRS consent for accounting method change, expected to be released in Q1'26 per the 10-K, but not yet reflected in the June 30, 2026 balance sheet (10-K 2025-09-30, Critical Accounting Policies - Income Taxes; 10-Q 2026-06-30, Balance Sheet shows Other liabilities of $104.7M vs $187.9M at Sept 2025).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual GAAP results through FY'25 show strong improvement: revenue grew 19% to $2.739B, operating income grew 67% to $982.4M, and diluted EPS grew 95% to $6.08 (10-K 2025-09-30, Consolidated Statements of Operations). However, quarterly comparisons are distorted by the Kepware and ThingWorx divestiture. Q3'26 revenue decreased 7% to $600.0M and operating income decreased 21% to $166.5M versus Q3'25, with the divested businesses contributing $46M of revenue in Q3'25 (10-Q 2026-06-30, MD&A Revenue). Nine-month FY'26 revenue grew 12% to $2.060B and operating income grew 25% to $683.4M, but net income of $876.0M includes the $463M divestiture gain (10-Q 2026-06-30, Consolidated Statements of Operations). Recurring revenue grew 14% in nine months FY'26 (10% constant currency) and ARR excluding divested businesses grew 7% (9% constant currency) (10-Q 2026-06-30, MD&A Results of Operations).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Operating cash flow has grown consistently across all comparable periods: FY'25 increased 16% to $867.7M versus FY'24 (10-K 2025-09-30, Consolidated Statements of Cash Flows); nine-month FY'26 increased 11% to $851.3M versus nine-month FY'25 (10-Q 2026-06-30, Consolidated Statements of Cash Flows); Q3'26 increased 7% to $260.6M versus Q3'25 (10-Q 2026-06-30, MD&A Executive Overview). Free cash flow showed similar growth: FY'25 +16% to $856.7M; nine-month FY'26 +10% to $835.0M; Q3'26 +3% to $249.3M (same sources). The company attributes cash flow growth to "resilient top-line growth due to our subscription business model and operational discipline" (10-Q 2026-06-30, MD&A Executive Overview). Nine-month FY'26 investing cash flow was positive $479.8M driven by $523.3M divestiture proceeds, versus negative $28.6M in the prior year (10-Q 2026-06-30, Consolidated Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

The balance sheet reflects active capital management. Total debt fell from $1.753B at September 2024 to $1.200B at September 2025 (redemption of 2025 senior notes), then rose to $1.425B at June 2026 as revolver borrowings increased from $231M to $475M to fund share repurchases (10-K 2025-09-30, Outstanding Debt; 10-Q 2026-06-30, Outstanding Debt). Cash and equivalents declined from $265.8M to $184.4M over FY'25, then rose to $351.5M at June 2026 due to divestiture proceeds and timing of tax payments (same sources). Stockholders' equity fell from $3.826B at September 2025 to $3.470B at June 2026, driven by $1.362B of share repurchases (including excise tax) reducing additional paid-in capital from $1.823B to $611M (10-Q 2026-06-30, Consolidated Statements of Stockholders' Equity). Net debt (total debt less cash) was approximately $1.07B at June 2026 versus $1.02B at September 2025 and $1.49B at September 2024. Deferred revenue (current) decreased from $812.3M to $700.3M, partly due to the divestiture (10-Q 2026-06-30, Consolidated Balance Sheets).

6. Data Gaps

• Standalone Q4 FY'25 and Q1 FY'26 income statement and cash flow figures (only nine-month and annual periods available; cannot isolate quarterly trends for those periods)
• Q2 FY'26 quarterly results (divestiture quarter) - only nine-month and Q3 figures provided in the Q3 10-Q
• ARR at September 30, 2024 and June 30, 2025 for direct quarterly ARR trajectory (only FY'25 year-end and Q3'26 figures provided)
• Segment-level operating profit trends (filings only disclose revenue by segment/geography)
• Full-year FY'26 guidance metrics beyond qualitative statements (no quantitative FY'26 outlook in provided filings)